Insider · CIK 0001410289

Szela Mary T

Reports to the SEC for 12 companies · WESTMINSTER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001410289

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-05	TLSITriSalus Life Sciences, Inc.F Tax Payment	Director, CEO and President	FTax Payment	−2,693 sh	$4.38	−$11.8K	1,074,990
2026-06-30	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+3,990 sh	$3.87	+$15.4K	1,077,683
2026-06-30	ABSIAbsci CorpP Purchase	Director	PPurchase	+12.9K sh	$11.54	+$149K	21,300
2026-06-04	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+35K sh	—	—	35,000
2026-06-04	ABSIAbsci CorpA Award	Director	AAward	+10.1K sh	—	—	10,100
2026-06-04	ABSIAbsci Corp · Stock Option (right to buy)A Award	Director	AAward	+39.8K sh	—	—	39,800
2026-06-04	ABSIAbsci CorpA Award	Director	AAward	+8,400 sh	—	—	8,400
2026-06-04	ABSIAbsci Corp · Stock Option (right to buy)A Award	Director	AAward	+33.2K sh	—	—	33,200
2026-05-15	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+39.7K sh	$2.59	+$103K	1,065,215
2026-03-17	TLSITriSalus Life Sciences, Inc.S Sale	Director, CEO and President	SSale	−15.9K sh	$3.85	−$61.4K	752,987
2026-03-11	TLSITriSalus Life Sciences, Inc.S Sale	Director, CEO and President	SSale	−4,358 sh	$4.13	−$18K	768,931
2026-02-23	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+30.5K sh	$4.10	+$125K	773,289
2025-12-31	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+2,100 sh	$4.38	+$9,198	1,023,826
2025-11-24	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+125K sh	—	—	442,802
2025-11-24	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+300K sh	—	—	742,802
2025-11-24	TLSITriSalus Life Sciences, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and President	AAward	+250K sh	—	—	1,578,182
2025-07-07	ABSIAbsci Corp · Stock Option (right to buy)A Award	Director	AAward	+178K sh	—	—	178,400
2025-06-30	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+2,848 sh	$4.23	+$12K	596,726
2025-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+28.5K sh	—	—	28,500
2025-02-18	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+21.1K sh	—	—	465,348
2025-01-30	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+5,010 sh	$5.28	+$26.5K	444,259
2025-01-29	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+5,030 sh	$5.03	+$25.3K	439,249
2025-01-28	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+4,716 sh	$5.12	+$24.1K	434,219
2025-01-27	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+40K sh	—	—	424,677
2025-01-27	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+4,826 sh	$5.42	+$26.2K	429,503
2025-01-27	TLSITriSalus Life Sciences, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and President	AAward	+240K sh	—	—	240,000
2024-12-31	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+3,530 sh	$4.26	+$15K	513,207
2024-09-13	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+1,295 sh	$4.83	+$6,254.85	378,677
2024-09-13	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+6,000 sh	$5.00	+$30K	384,677
2024-09-12	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+7,520 sh	$5.20	+$39.1K	377,382
2024-09-10	TLSITriSalus Life Sciences, Inc.P Purchase	Director, CEO and President	PPurchase	+5,000 sh	$4.97	+$24.9K	369,862
2024-06-20	Omega Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-06-05	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2024-02-13	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+84.9K sh	—	—	364,862
2024-02-13	TLSITriSalus Life Sciences, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and President	AAward	+289K sh	—	—	288,750
2024-02-13	TLSITriSalus Life Sciences, Inc.A Award	Director, CEO and President	AAward	+125K sh	—	—	317,802
2023-08-14	TLSITriSalus Life Sciences, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO and President	AAward	+173K sh	—	—	172,500
2023-06-16	Prometheus Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2,071 sh	—	—	0
2023-06-16	Prometheus Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2023-06-16	Prometheus Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.5K sh	—	—	0
2023-06-07	Omega Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,118
2023-05-31	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+26K sh	—	—	26,000
2023-05-19	Prometheus Biosciences, Inc.A Award	Director	AAward	+2,071 sh	—	—	2,071
2022-06-21	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2022-06-08	Omega Therapeutics, Inc.Option (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,118
2022-05-19	Prometheus Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20.5K sh	—	—	20,500
2021-06-22	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000
2021-03-11	Prometheus Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-01-11	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-24	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Director	AAward	+23K sh	—	—	23,000

Recent filings

Accepted (ET)
Oct 74
Szela Mary T0001628280-26-065323
SEC(opens sec.gov)
Jul 64
Szela Mary T0001672688-26-000124
SEC(opens sec.gov)
Jul 14
Szela Mary T0001628280-26-046519
SEC(opens sec.gov)
Jul 15
Szela Mary T0001628280-26-046511
SEC(opens sec.gov)
Jun 154/A
Szela Mary T0001672688-26-000116
SEC(opens sec.gov)
Jun 84
Szela Mary T0001470831-26-000526
SEC(opens sec.gov)
Jun 44
Szela Mary T0001193125-26-257897
SEC(opens sec.gov)
May 184
Szela Mary T0001628280-26-035994
SEC(opens sec.gov)
Mar 204
Szela Mary T0001628280-26-020186
SEC(opens sec.gov)
Feb 234
Szela Mary T0001628280-26-010603
SEC(opens sec.gov)
Nov 254
Szela Mary T0001410289-25-000006
SEC(opens sec.gov)
Jul 94
Szela Mary T0001628280-25-034662
SEC(opens sec.gov)

Companies

Address

6272 W. 91ST AVENUE

WESTMINSTER, CO, 80031